| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q5127 |
Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg |
177 |
142 |
$581K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,972 |
16,245 |
$428K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
603 |
480 |
$413K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
95 |
80 |
$247K |
| J1449 |
Injection, eflapegrastim-xnst, 0.1 mg |
66 |
55 |
$236K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
1,483 |
903 |
$200K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,485 |
5,440 |
$194K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,800 |
6,536 |
$174K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,174 |
8,721 |
$159K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,396 |
2,813 |
$152K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,802 |
2,014 |
$135K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
408 |
320 |
$126K |
| 99205 |
Prolong outpt/office vis |
1,420 |
1,414 |
$95K |
| J3590 |
Unclassified biologics |
17 |
12 |
$59K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
21 |
16 |
$50K |
| 96417 |
|
1,598 |
1,224 |
$42K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
338 |
199 |
$41K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
5,091 |
3,587 |
$35K |
| J1627 |
Injection, granisetron, extended-release, 0.1 mg |
57 |
37 |
$29K |
| 96367 |
|
853 |
656 |
$26K |
| 99215 |
Prolong outpt/office vis |
422 |
397 |
$17K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
591 |
299 |
$16K |
| J0185 |
Injection, aprepitant, 1 mg |
76 |
60 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,066 |
1,574 |
$11K |
| J2820 |
Injection, sargramostim (gm-csf), 50 mcg |
29 |
12 |
$8K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,536 |
1,948 |
$3K |
| 96415 |
|
111 |
88 |
$2K |
| 99222 |
Initial hospital care, per day, moderate complexity |
36 |
36 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
25 |
$1K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
87 |
62 |
$1K |
| J3489 |
Injection, zoledronic acid, 1 mg |
40 |
37 |
$882.89 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35 |
34 |
$449.49 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
74 |
56 |
$240.48 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
221 |
200 |
$239.28 |
| 96411 |
|
14 |
12 |
$213.36 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
31 |
25 |
$166.24 |
| 36415 |
Collection of venous blood by venipuncture |
232 |
198 |
$0.00 |
| 99497 |
|
15 |
15 |
$0.00 |